Sodiq Ojuroungbe The Director General of the Nigerian Institute of Medical Research, Professor Babatunde Salako, says the institute has focused more attention on the fight against drug-resistant tuberculosis as its latest research reveals alarming trends in TB drug resistance. He said the discovery necessitates taking urgent national measures to enhance treatment efficacy and control. Speaking at a press briefing to mark the end of his eight-year tenure as DG of the institute, the professor said it was discovered that traditional treatments are increasingly ineffective against these resistant strains, thus, posing a significant challenge to TB control efforts.
Salako stressed the critical need for innovative approaches, stating, “The escalating rates of drug-resistant tuberculosis demand immediate action. We must strengthen diagnostic capabilities, expand treatment options, and prioritise research into new therapies to combat this growing public health threat.” The NIMR DG said under his leadership, the institute served as a pivotal national reference centre for tuberculosis, conducting essential research and diagnostic services.
He added that the institute’s efforts include genetic studies to understand the underlying mechanisms of drug resistance, informing strategies for more effective TB management and control. Beyond tuberculosis, Salako explained that NIMR has played a crucial role in addressing other infectious diseases such as HIV/AIDS and malaria, contributing .
